1302 — LifeTech Scientific Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual income statement for LifeTech Scientific, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	642	925	1,097	1,267	1,304
Cost of Revenue
Gross Profit	513	748	874	996	981
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Operating Interest Expense / Income
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	378	597	729	884	1,117
Operating Profit	264	329	368	383	186
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	243	333	378	176	199
Provision for Income Taxes
Net Income After Taxes	207	283	319	107	168
Minority Interest
Net Income Before Extraordinary Items
Net Income	216	292	325	263	222
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	216	292	325	263	222
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.048	0.063	0.076	0.059	0.063